5 completed, 1 terminated. 6 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 5, Terminated 1 |
Follow Impaired Renal Function: new trials by email Literature Review of Impaired Renal Function trials Research Report on Impaired Renal Function
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Aldafermin (NGM282) in Participants With Impaired Renal Function Aldafermin (NGM282) - Impaired Renal Function | Phase 1 | Completed | NGM Biopharmaceuticals, Inc | 48 | 2019-11-08 | 2020-04-27 |
| RI Study to Assess and Compare the Pharmacokinetic Parameters of MD1003 in Renal Impaired Patients and Healthy Subjects MD1003 - Healthy Volunteers, Impaired Renal Function | Phase 1 | Terminated | MedDay Pharmaceuticals SA | 24 | 2019-10-09 | 2020-05-13 |
| A Study to Evaluate the Effects of Renal Impairment on the Pharmacokinetics of ELX-02 ELX-02 - Impaired Renal Function | Phase 1 | Completed | Eloxx Pharmaceuticals, Inc. | 24 | 2019-01-04 | 2021-04-13 |
| A Phase 1 Study of Roxadustat in Subjects With Different Degrees of Renal Function Roxadustat - Normal Renal Function, Impaired Renal Function | Phase 1 | Completed | Astellas Pharma Europe B.V. | 34 | 2016-12-12 | 2020-02-12 |
| Evaluation of Renal Function Impairment on the Pharmacokinetics of LEE011 LEE011 - Normal Renal Function, Impaired Renal Function | Phase 1 | Completed | Novartis Pharmaceuticals | 38 | 2015-10-23 | 2020-12-19 |
| Study of SSP-004184 (FBS0701) in Healthy Adults and Elderly Subjects and in Subjects With Impaired Renal Function SSP-004184 - Impaired Renal Function | Phase 1 | Completed | Shire | 66 | 2012-10-29 | 2021-06-10 |
Female Urogenital Diseases (6) · Female Urogenital Diseases and Pregnancy Complications (6) · Kidney Diseases (6) · Male Urogenital Diseases (6) · Urogenital Diseases (6) · Urologic Diseases (6)
4,5-dihydro-2-(2-hydroxy-3-(3,6,9-trioxadecyloxy)phenyl)-4-methyl-4-thiazolecarboxylic acid (1) · ELX-02 (1) · aldafermin (1) · ribociclib (1) · roxadustat (1)
Astellas Pharma Europe B.V. (1) · Eloxx Pharmaceuticals, Inc. (1) · MedDay Pharmaceuticals SA (1) · NGM Biopharmaceuticals, Inc (1) · Novartis Pharmaceuticals (1) · Shire (1)
United States (4) · Germany (2) · Bulgaria (1) · Czechia (1) · France (1) · Hungary (1) · United Kingdom (1)
2015 (1), 2019 (1)